SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                        Date of Report: October 16, 2008
                        (Date of earliest event reported)

                                VASOMEDICAL, INC.
                                -----------------
             (Exact name of registrant as specified in its charter)


    Delaware                        0-18105                      11-2871434
--------------------------------------------------------------------------------
(State or other                  (Commission                   (IRS Employer
 jurisdiction of                 File Number)                  Identification
 incorporation)                                                   Number)


 180 Linden Avenue, Westbury, New York                             11590
 -------------------------------------                             -----
(Address of principal executive offices)                         (Zip Code)



Registrant's telephone number including area code               (516) 997-4600
                                                                --------------


                                 Not applicable
                                 --------------

          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b)

[ ] Pre-commencement  communications  pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)


     Item 5.02  Departure  of  Directors  or  Certain   Officers;   Election  of
          Directors;  Appointment of Certain Officers; Compensatory Arrangements
          of Certain Officers.


     Effective  October 16, 2008,  Jun Ma, PhD, a director of the Company  since
June  2007,  was  appointed  by the Board of  Directors  as its Chief  Executive
Officer  and  President,  to  serve  at the  pleasure  of the  Board.  Mr.  Ma's
compensation will be at the annual rate of $100,000. Mr. Ma holds a BS degree in
precision  machinery and  instrumentation  from China  University of Science and
Technology, an MS degree in biomedical instrumentation from Shanghai University,
and a PhD degree in mechanical  engineering from Columbia University in the city
of New York.  He has been an  associate  professor  in  engineering  at New York
Institute of Technology since 1997 and an assistant professor from 1993 to 1997.
Mr. Ma currently provides  consulting  services to several companies,  including
Kerns  Manufacturing  Corp. and Living Data Technology  Corp.,  both of whom are
shareholders  of our Company.  Mr. Ma replaces John C. K. Hui, PhD, who has been
appointed Vice Chairman of the Board of Directors and Chief Technology Officer.


                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                       VASOMEDICAL, INC.


                                       By: /s/ Jun Ma
                                           -------------------------------------
                                           President and Chief Executive Officer

Dated:   October 16, 2008